Outrage and Grief Follow Death of Coronavirus Whistleblower

Authorities had silenced Li Wenliang after he spoke out about the virus, now known as 2019-nCoV, in the early days of the epidemic.

Written byAmy Schleunes
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Li Wenliang, a Chinese ophthalmologist who voiced an early warning about the coronavirus that has since infected more than 31,000 people, died today (February 7) after contracting the disease himself, according to People’s Daily. The New York Times reports that Li’s attempts to warn the Wuhan community about the virus early on were shut down by local police and medical officials. Li was 34 years old, married, and expecting his second child.

“A hero who released information about Wuhan’s epidemic in the early stage, Dr. Li Wenliang is immortal,” writes Zen Guang, chief scientist at the China Center for Disease Control, on the Sina Weibo microblog service, according to the Associated Press.

“We will not forget the doctor who spoke up about an illness that was called rumor,” one person commented in reaction to an announcement of Li’s death on Weibo by Wuhan City Central Hospital, where Li had worked ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • A former intern at The Scientist, Amy studied neurobiology at Cornell University and later earned her MFA in creative writing from the University of Iowa. She is a Los Angeles–based writer, editor, and communications strategist who collaborates on nonfiction books for Harper Collins and Houghton Mifflin Harcourt, and also teaches writing at Johns Hopkins University CTY. Her favorite projects involve sharing the insights of science and medicine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies